This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
MOUNTAIN VIEW, Calif.,
March 2, 2012 /PRNewswire/ -- IRIDEX Corporation (NASDAQ: IRIX) today announced that management is scheduled to make investor presentations at investment conferences this month.
The Company presents today at the Lazard Capital Markets Annual Medical Technology Snowbird Conference where President and CEO
Dominik Beck will host a series of one-on-one meetings with institutional investors throughout the day.
The Company is also scheduled to present at the ROTH Annual Growth Stock Conference during which President and CEO
Dominik Beck and CFO
Jim Mackaness are scheduled to present at
1:30 p.m. Pacific Time on Wednesday, March 14th. The conference is being held
March 11-14th at the Ritz-Carlton in
Dana Point, CA. A live audio webcast of the ROTH presentation will be available in the Investors section of the IRIDEX website at
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in
the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into 107 countries. For further information, visit the Company's website at
SOURCE IRIDEX Corporation